Randomized controlled trial of hysteroscopy or ultrasonography versus no guidance during D&C after uterine artery chemoembolization for cesarean scar pregnancy

Int J Gynaecol Obstet. 2016 Nov;135(2):158-162. doi: 10.1016/j.ijgo.2016.04.019. Epub 2016 Aug 5.

Abstract

Objective: To compare the complication rates after uterine artery chemoembolization (UACE) followed by dilation and curettage (D&C) guided by different types of monitoring for treatment of cesarean scar pregnancy (CSP).

Methods: A randomized controlled trial was undertaken of women with CSP attending a hospital in Wuhan, China, between June 1, 2010, and June 30, 2014. Using sealed opaque envelopes containing random numbers, participants were randomly allocated to undergo D&C with hysteroscopy monitoring, ultrasonography monitoring, or no monitoring. Participants and investigators were masked to group assignment. The primary outcome was the number of participants with complications at 2 months of follow-up after D&C. Analyses were by intention to treat.

Results: Among 144 participants, 48 were assigned to hysteroscopy monitoring, 44 to ultrasonography monitoring, and 52 to no monitoring. Complications were noted for 1 (2.1%) patient in the hysteroscopy group, 2 (4.5%) in the ultrasonography group, and 12 (23.1%) in the no monitoring group (P=0.001).

Conclusion: Hysteroscopy or ultrasonography monitoring of D&C after UACE for CSP treatment can decrease the complication rate. ClinicalTrials.gov: NCT02357095.

Keywords: Cesarean scar pregnancy; Hysteroscopy monitoring; Ultrasonography monitoring; Uterine artery chemoembolization.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Blood Loss, Surgical
  • China
  • Cicatrix / etiology
  • Dilatation and Curettage / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Hysteroscopy*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Pregnancy
  • Pregnancy, Ectopic / surgery*
  • Prospective Studies
  • Surgery, Computer-Assisted / methods*
  • Treatment Outcome
  • Ultrasonography*
  • Uterine Artery Embolization / methods*
  • Uterine Hemorrhage / epidemiology
  • Young Adult

Substances

  • Methotrexate

Associated data

  • ClinicalTrials.gov/NCT02357095